- Home
- CATX vs EVAC Comparison
CATX vs EVAC Comparison
Compare CATX & EVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.95
N/A
Current Price
$10.18
Company Overview
Basic Information| Metric | CATX | EVAC |
|---|---|---|
| Founded | 1983 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 497.9M | 592.7M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | CATX | EVAC |
|---|---|---|
| Price | $2.95 | $10.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $12.11 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 102.1K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.96 | $9.90 |
| 52 Week High | $6.16 | $10.20 |
Technical Indicators
Market Signals| Indicator | CATX | EVAC |
|---|---|---|
| Relative Strength Index (RSI) | 33.38 | 56.67 |
| Support Level | $2.85 | $10.12 |
| Resistance Level | $2.96 | N/A |
| Average True Range (ATR) | 0.16 | 0.01 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 33.33 | 66.67 |
Price Performance
Historical Comparison CATX
EVAC
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About EVAC EQV Ventures Acquisition Corp. II Class A Ordinary Shares
EQV Ventures Acquisition Corp II is a blank check company.